Global Hemodynamic Monitoring System Market Research Report—Forecast till 2027

$4,450$6,250

Global Hemodynamic Monitoring System Market is anticipated to exhibit a healthy CAGR of 6.48% during the forecast period of 2020 to 2027.

Clear

Description

Global Hemodynamic Monitoring System Market Forecast

Market Overview
Global Hemodynamic Monitoring System Market is anticipated to exhibit a healthy CAGR of 6.48% during the forecast period of 2020 to 2027. The global market is primarily attributed to the rising number of critically ill geriatric cases, increasing prevalence of cardiovascular disorders & diabetes, growing demand for home-based and non-invasive monitoring systems, and technological evolution in the hemodynamic monitoring system.

The global hemodynamic monitoring system is expected to witness a notable market owing to the highest value of USD 1,265.60 Million in 2019. Moreover, many major market players focus more on making these hemodynamic monitoring systems technologically expanded to meet the growing product demand through mergers and acquisitions, and product launches.

The growth of technologically advanced minimally invasive or non-invasive products for the hemodynamic monitoring system has raised its sales in-home care settings and clinics.

Market Segmentation
Global Hemodynamic Monitoring System Market has been segmented into Type, Product, and End User.

In terms of type segment, the global market has been classified into invasive, minimally invasive, and non-invasive hemodynamic monitoring systems. The non-invasive hemodynamic monitoring system segment is expected to register the highest CAGR of 7.73% during the forecast period.

By product type, the market has been divided into hemodynamic monitoring systems and disposables.

The disposables segment was valued at USD 786.75 million in 2019. The segment is expected to dominate the market due to the rising demand for disposables used for the diagnosis and treatment of critically ill patients.

Based on the end-user segment, the hemodynamic monitoring system market has been classified into hospitals & clinics, ambulatory care centers, and others. The hospitals and clinics segment is expected to dominate the market owing to the growing number of hospitals and clinics and the rapid adoption of advanced technologies in many clinics.

Regional Analysis
The region-specific analysis of the Global Hemodynamic Monitoring System Market has been studied across the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is likely to lead the market owing to the rising prevalence of cardiovascular diseases & diabetes, product launch, and acquisition in this region.

Europe contributed a substantial share of 29.8% in the global market owing to the companies’ organic growth strategies and a well-developed medical industry in the region. Asia-Pacific is expected to register a fastest-growing market owing to the high incidence of cardiovascular diseases, COPD, and diabetes.

The hemodynamic monitoring system market in Middle East & Africa is anticipated to register a limited growth during the forecast period owing to the increasing prevalence of cardiac disorders and diabetes, rising in the number of critically ill geriatric cases, advancements in technology, funding by private players and government bodies, the growing demand for home-based and non-invasive monitoring systems, and the increasing number of people suffering from hypertension.

 

Major Players
The Prominent players in the global hemodynamic monitoring system market are Edwards Lifesciences Corporation, Getinge AB, Baxter International Inc., Drägerwerk AG & Co. KGaA, LiDCO Group, Osypka Medical GmbH, Deltex Medical, ICU Medical, CNSYSTEMS MEDIZINTECHNIK GMBH, and NI Medical.

 

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries.

Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Global Hemodynamic Monitoring Devices Market: Focus on Product, Modality, Setting, and 21 Countries & Analysis and Forecast, 2021-2030

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENT
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 16

2.2 RESEARCH OBJECTIVE 16

2.3 MARKET STRUCTURE 16

2.4 ASSUMPTIONS & LIMITATIONS 17

3 RESEARCH METHODOLOGY
3.1 DATA MINING 18

3.2 SECONDARY RESEARCH 19

3.3 PRIMARY RESEARCH 20

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 21

3.5 FORECASTING TECHNIQUES 21

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22

3.6.1 BOTTOM-UP APPROACH 24

3.6.2 TOP-DOWN APPROACH 24

3.7 DATA TRIANGULATION 25

3.8 VALIDATION 25

4 MARKET DYNAMICS
4.1 OVERVIEW 26

4.2 DRIVERS 27

4.2.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASE AND LIFESTYLE RELATED DISEASES 27

4.2.2 RISING DEMAND FOR MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEM 27

4.2.3 TECHNOLOGICAL ADVANCEMENTS IN HEMODYNAMICS MONITORING SYSTEM 27

4.2.4 FAVORABLE GOVERNMENT INITIATIVES TO CREATE AWARENESS ABOUT CARDIOVASCULAR DISEASES 28

4.3 RESTRAINTS 28

4.3.1 RISKS ASSOCIATED WITH HEMODYNAMIC MONITORING SYSTEM 28

4.4 OPPORTUNITY 29

4.4.1 EMERGING MARKET PLAYERS IN THE HEMODYNAMIC MONITORING SYSTEM 29

5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS 30

5.1.1 R&D AND DESIGNING 31

5.1.2 MANUFACTURING 31

5.1.3 DISTRIBUTION & SALES 31

5.1.4 POST-SALES MONITORING 31

5.2 PORTER’S FIVE FORCES MODEL 32

5.2.1 BARGAINING POWER OF SUPPLIERS 32

5.2.2 BARGAINING POWER OF BUYERS 33

5.2.3 THREAT OF NEW ENTRANTS 33

5.2.4 THREAT OF SUBSTITUTES 33

5.2.5 INTENSITY OF RIVALRY 33

5.3 COVID-19 IMPACT ANALYSIS 34

5.3.1 DEMAND SUPPLY ANALYSIS 34

5.3.2 IMPACT ON MAJOR REGIONS (AMERICAS, EUROPE, ASIA-PACIFIC, AND THE MIDDLE EAST & AFRICA) 34

5.3.3 IMPACT ON KEY PLAYERS 35

6 GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE
6.1 OVERVIEW 36

6.2 INVASIVE HEMODYNAMIC MONITORING SYSTEM 37

6.3 MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEM 38

6.4 NON-INVASIVE HEMODYNAMIC MONITORING SYSTEM 38

7 GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT
7.1 OVERVIEW 40

7.2 HEMODYNAMIC MONITORING SYSTEMS 41

7.3 DISPOSABLES 42

8 GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER
8.1 OVERVIEW 43

8.2 HOSPITALS & CLINICS 44

8.3 AMBULATORY CARE CENTERS 44

8.4 OTHERS 45

9 GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION
9.1 OVERVIEW 46

9.2 AMERICAS 48

9.2.1 NORTH AMERICA 50

9.2.1.1 US 52

9.2.1.2 CANADA 54

9.2.2 LATIN AMERICA 56

9.3 EUROPE 58

9.3.1 WESTERN EUROPE 60

9.3.1.1 GERMANY 62

9.3.1.2 FRANCE 64

9.3.1.3 UK 66

9.3.1.4 ITALY 67

9.3.1.5 SPAIN 69

9.3.1.6 REST OF WESTERN EUROPE 71

9.3.2 EASTERN EUROPE 72

9.4 ASIA-PACIFIC 75

9.4.1 JAPAN 78

9.4.2 CHINA 79

9.4.3 INDIA 81

9.4.4 AUSTRALIA 83

9.4.5 SOUTH KOREA 84

9.4.6 REST OF ASIA-PACIFIC 86

9.5 MIDDLE EAST & AFRICA 88

9.5.1 MIDDLE EAST 90

9.5.2 AFRICA 92

10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW 94

10.2 COMPETITIVE BENCHMARKING 96

10.3 COMPETITOR DASHBOARD 97

10.4 MAJOR GROWTH STRATEGY IN THE GLOBAL HEMODYNAMIC MONITORING DEVICES MARKET 98

10.5 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL HEMODYNAMIC MONITORING DEVICES MARKET 99

10.6 KEY DEVELOPMENT ANALYSIS 99

10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 100

10.7.1 PRODUCT LAUNCH/PRODUCT APPROVAL 100

10.7.2 MERGERS/ACQUISITIONS 101

10.7.3 PARTNERSHIPS/AGREEMENTS 102

11 COMPANY PROFILES
11.1 EDWARDS LIFESCIENCES CORPORATION 103

11.1.1 COMPANY OVERVIEW 103

11.1.2 FINANCIAL OVERVIEW 104

11.1.3 PRODUCTS/SERVICES OFFERED 104

11.1.4 KEY DEVELOPMENTS 105

11.1.5 SWOT ANALYSIS 106

11.1.6 KEY STRATEGIES 107

11.2 GETINGE AB 108

11.2.1 COMPANY OVERVIEW 108

11.2.2 FINANCIAL OVERVIEW 108

11.2.3 PRODUCTS/SERVICES OFFERED 109

11.2.4 KEY DEVELOPMENTS 109

11.2.5 SWOT ANALYSIS 110

11.2.6 KEY STRATEGIES 110

11.3 BAXTER INTERNATIONAL INC. 111

11.3.1 COMPANY OVERVIEW 111

11.3.2 FINANCIAL OVERVIEW 111

11.3.3 PRODUCTS/SERVICES OFFERED 112

11.3.4 KEY DEVELOPMENTS 112

11.3.5 SWOT ANALYSIS 113

11.3.6 KEY STRATEGIES 113

11.4 DRÄGERWERK AG & CO. KGAA 114

11.4.1 COMPANY OVERVIEW 114

11.4.2 FINANCIAL OVERVIEW 114

11.4.3 PRODUCTS/SERVICES OFFERED 115

11.4.4 KEY DEVELOPMENTS 115

11.4.5 SWOT ANALYSIS 116

11.4.6 KEY STRATEGIES 116

11.5 LIDCO GROUP 117

11.5.1 COMPANY OVERVIEW 117

11.5.2 FINANCIAL OVERVIEW 117

11.5.3 PRODUCTS/SERVICES OFFERED 118

11.5.4 KEY DEVELOPMENTS 118

11.5.5 SWOT ANALYSIS 119

11.5.6 KEY STRATEGIES 119

11.6 OSYPKA MEDICAL GMBH 120

11.6.1 COMPANY OVERVIEW 120

11.6.2 FINANCIAL OVERVIEW 120

11.6.3 PRODUCTS/SERVICES OFFERED 120

11.6.4 KEY DEVELOPMENTS 120

11.6.5 SWOT ANALYSIS 121

11.6.6 KEY STRATEGIES 121

11.7 DELTEX MEDICAL 122

11.7.1 COMPANY OVERVIEW 122

11.7.2 FINANCIAL OVERVIEW 122

11.7.3 PRODUCTS/SERVICES OFFERED 122

11.7.4 KEY DEVELOPMENTS 123

11.7.5 SWOT ANALYSIS 124

11.7.6 KEY STRATEGIES 124

11.8 ICU MEDICAL 125

11.8.1 COMPANY OVERVIEW 125

11.8.2 FINANCIAL OVERVIEW 125

11.8.3 PRODUCTS/SERVICES OFFERED 126

11.8.4 KEY DEVELOPMENTS 126

11.8.5 SWOT ANALYSIS 126

11.8.6 KEY STRATEGIES 126

11.9 CNSYSTEMS MEDIZINTECHNIK GMBH 127

11.9.1 COMPANY OVERVIEW 127

11.9.2 FINANCIAL OVERVIEW 127

11.9.3 PRODUCTS/SERVICES OFFERED 127

11.9.4 KEY DEVELOPMENTS 127

11.9.5 SWOT ANALYSIS 128

11.9.6 KEY STRATEGIES 128

11.10 NI MEDICAL 129

11.10.1 COMPANY OVERVIEW 129

11.10.2 FINANCIAL OVERVIEW 129

11.10.3 PRODUCTS/SERVICES OFFERED 129

11.10.4 KEY DEVELOPMENTS 129

11.10.5 SWOT ANALYSIS 130

11.10.6 KEY STRATEGIES 130

12 APPENDIX
12.1 REFERENCES 131

12.2 RELATED REPORTS 131